An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Food on Oxycodone Pharmacokinetics Following Oral 40 Mg Doses of PF-00345439 Formulation K and to Estimate Its Relative Bioavailability of Oxycodone Compared to PF-003454390 Formulation X in the Fasted State in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 07 Oct 2013 Planned patient number (18) added as reported by ClinicalTrials.gov.
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2013 New trial record